Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 8Other hematologic neoplasm 7Lymphoid 7Plasma cell 6Gastrointestinal 6Myeloid 5Gynecologic 5CNS 4Thoracic 3Head & Neck 2Genitourinary 2Dermatologic 2Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Pruritus 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Aprepitant × Thoracic × Clear all
NCT02646020 2021-05-18

EGFR-TKIs

Sun Yat-sen University

Phase 2 Completed
138 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT02364804 2020-09-01

A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

Shiga University

Completed
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02161991 2020-03-26

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

Hunan Province Tumor Hospital

Phase 3 Completed
244 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡